Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur-0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients

Author： Sakata Y.   Ohtsu A.   Horikoshi N.   Sugimachi K.   Mitachi Y.   Taguchi T.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.34, Iss.11, 1998-10, pp. : 1715-1720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

By Oki Yasunari   Hirose Takashi   Yamaoka Toshimitsu   Kusumoto Sojiro   Shirai Takao   Sugiyama Tomohide   Okuda Kentaro   Nakashima Masanao   Murata Yasunori   Ohmori Tohru   Adachi Mitsuru  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 791-797

Springer Publishing Company

Access to resources Recommend Favorite

Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer

By Kinoshita Taira   Nashimoto Atsushi   Yamamura Yoshitaka   Okamura Takeshi   Sasako Mitsuru   Sakamoto Junichi   Kojima Hiroshi   Hiratsuka Masahiro   Arai Kuniyoshi   Sairenji Motonori   Fukushima Norimasa   Kimura Hironobu   Nakajima Toshifusa  

Gastric Cancer, Vol. 7, Iss. 2, 2004-06 ,pp. : 104-109

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer

By Ueda Yuji   Yamagishi Hisakazu   Ichikawa Daisuke   Okamoto Kazuma   Otsuji Eigo   Morii Jun   Koizumi Kinya   Kakihara Naoki   Shimotsuma Masataka   Yamashita Tetsuro   Taniguchi Fumihiro   Aragane Hideki   Nishi Hiroshi   Itokawa Yoshiki   Morita Satoshi   Sakamoto Junichi  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 149-154

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug

By Urata Yoshiko   Negoro Shunichi   Satouchi Miyako   Kurata Takayasu   Yoshimura Sho   Shimada Temiko   Takada Yoshiki  

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 103-107

Humana Press, Inc

Access to resources Recommend Favorite

A Phase I Study of Triplet Combination Chemotherapy of Paclitaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer

By Kimura Yutaka   Yano Hiroshi   Imamura Hiroshi   Fujitani Kazumasa   Imano Motohiro   Tokunaga Yukihiko   Matsuoka Masaki   Kurokawa Yukinori   Shimokawa Toshio   Takiuchi Hiroya   Tsujinaka Toshimasa   Furukawa Hiroshi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 125-131

Oxford University Press

Access to resources Recommend Favorite